c-erbB-2 oncoprotein expression in primary and advanced breast cancer.

Immunoreactivity for c-erbB-2 oncogene product expression has been investigated in patients with breast cancer using the polyclonal antibody 21N. Three series of patients were studied, 602 presenting with primary operable cancer, 57 with stage 3 and 123 with stage 4 disease. Representative tissue se...

Descripción completa

Detalles Bibliográficos
Autores principales: Lovekin, C., Ellis, I. O., Locker, A., Robertson, J. F., Bell, J., Nicholson, R., Gullick, W. J., Elston, C. W., Blamey, R. W.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1991
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971868/
https://www.ncbi.nlm.nih.gov/pubmed/1672254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971868/
https://www.ncbi.nlm.nih.gov/pubmed/1672254

Ejemplares similares